# Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers

> **NCT02632877** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 60 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Pirfenidone with MODD
- **DRUG:** Ketanserin

## Key facts

- **NCT ID:** NCT02632877
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632877, "Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02632877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*